Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus alogl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Metab J
Hauptverfasser: Kim, Jeong Mi, Kim, Sang Soo, Kim, Jong Ho, Kim, Mi Kyung, Kim, Tae Nyun, Lee, Soon Hee, Lee, Chang Won, Park, Ja Young, Kim, Eun Sook, Lee, Kwang Jae, Choi, Young Sik, Kim, Duk Kyu, Kim, In Joo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Diabetes Association 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://ncbi.nlm.nih.gov/pubmed/31339011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0274
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge